CVS Health Files 8-K Report

Ticker: CVS · Form: 8-K · Filed: 2025-08-15T00:00:00.000Z

Sentiment: neutral

Topics: filing, corporate-reporting

Related Tickers: CVS

TL;DR

CVS Health filed a routine 8-K, no major news yet.

AI Summary

On August 11, 2025, CVS Health Corporation filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. No specific new material events or financial figures were detailed in the provided excerpt.

Why It Matters

This filing indicates routine corporate reporting by CVS Health, providing updates on events and financial exhibits to the SEC.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without any disclosed material events or negative news.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for CVS Health?

The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine corporate reporting.

When was the earliest event reported in this filing?

The earliest event reported is August 11, 2025.

What is CVS Health's state of incorporation?

CVS Health's state of incorporation is Delaware.

What is the principal executive office address for CVS Health?

The address is One CVS Drive, Woonsocket, Rhode Island, 02895.

Does this filing disclose any specific new financial results or material events?

Based on the provided excerpt, no specific new financial results or material events are detailed; it appears to be a standard filing.

From the Filing

0001193125-25-181862.txt : 20250815 0001193125-25-181862.hdr.sgml : 20250815 20250815161049 ACCESSION NUMBER: 0001193125-25-181862 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20250811 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250815 DATE AS OF CHANGE: 20250815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 251224712 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 d32562d8k.htm 8-K 8-K CVS HEALTH Corp false 0000064803 0000064803 2025-08-11 2025-08-11     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2025       CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter)       Delaware   001-01011   05-0494040 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   One CVS Drive , Woonsocket , Rhode Island   02895 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (401) 765-1500 Former name or former address, if changed since last report: N/A     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   CVS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Section 8 – Other Events   Item 8.01 Other Events. On August 11, 2025, CVS Health Corporation, a Delaware corporation (the “Company”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several underwriters named in Schedule I thereto (collectively, the “Underwriter

View on Read The Filing